TERACT Appoints Ledouble as Independent Expert for Proposed Buy-Out Offer

On January 22, 2026, TERACT's Board of Directors appointed Ledouble, represented by Mr. Olivier Cretté, as an independent expert. This follows the intention of InVivo Group and Founders Companies to initiate a public buy-out offer for TERACT shares, followed by a squeeze-out. This decision was based on a recommendation from an ad hoc committee of independent directors, including Ewa Brandt, Marie-Amélie de Leusse, and Louis Molis.

The independent expert will assess the fairness of the financial terms of the offer. The ad hoc committee will oversee the expert's work. The final report and TERACT's Board reasoned opinion will be part of the draft response document to be filed with the Autorité des Marchés Financiers (AMF).